Lung cancer is the second most diagnosed and the leading cause of cancer-related death, claiming nearly 1.8 million lives1 worldwide in 2020. By mid-2021, an estimated 235,760 new cases and 131,880 deaths from lung cancer have been reported in the United States.2
There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC, a slowly progressing lung cancer with few-to-no symptoms well into the advanced stage, accounts for 80 to 85% of patient diagnoses.3 SCLC, a rapidly growing and spreading cancer, accounts for 10-15% of all lung cancer diagnoses.3
While fragmentation of the healthcare system can impede consistent access to equitable care, gaps in the quality of cancer care delivery persist among certain patient populations due to prevailing social determinants of health4 and contribute to suboptimal outcomes.5-6
ACCC has designed a quality benchmark to define ideal care for patients with stages III and IV non-small cell lung cancer, with an emphasis on leveraging the expertise of the multidisciplinary cancer team.
Explore Quality NSCLC Recommendations
Access new recommendations for defining high-quality care for this patient population through scientific presentations, infographics, and video summaries—broken down by multidisciplinary care team focus.
Explore this robust resource bank of curated nationally-available materials to support your NSCLC patients. Filter by target audience (your clinical care team or your patients), cancer stage, or by keyword.
In order to identify and reduce barriers to care experienced by lung cancer patients covered by Medicaid, ACCC created a model framework to help cancer programs evaluate their current state of care coordination and identify areas of improvement.
Assess Your Cancer Program
6 Steps to Improve Care Coordination
See how this free, interactive online tool can help evaluate the current state of care coordination for lung cancer patients at your cancer program or practice, and identify focus areas for improvement and next steps.
Access Full Report
To leverage assessment results for the development of quality improvement projects, the Full Report is an ideal starting place. Its 12 Assessment Areas map to more than 100 quality measures for collecting and reporting data.
Optimizing Advanced NSCLC Biomarker Testing, Treatment, and Management
This enduring material was recorded from an interactive, virtual (live) summit to enhance coordination of patient care and gain deeper scientific knowledge, skills, and competence in biomarker testing practices, treatment selection, and management of adverse events in patients with advanced NSCLC. This activity offers up to 4.5 hours of CME/CMLE credit.
Biomarker Testing Implementation Roadmap for Advanced NSCLC
An innovative tool to implement, expand, and sustain biomarker testing for patients with advanced NSCLC.
Biomarker Testing Resource Library
Curated materials to support the implementation of biomarker testing for patients with advanced NSCLC.
Read how these ACCC Cancer Program Members have developed innovative programs to provide efficient, quality care to their patients with lung cancer.
Read More Blog Posts
Evolving Biomarkers in NSCLC
Eliminating Precision Medicine Disparities
Improving Care Coordination: A Model for Lung Cancer
Improving Care Delivery for Stages III and IV NSCLC
Optimizing Advanced NSCLC Biomarker Testing, Treatment and Management
Operational Pathways for Molecular Testing in NSCLC
Patient-Centered Small Cell Lung Cancer Care
Best Practices in Early Stage NSCLC
This project will promote online collaborations among clinicians involved in the care of patients with early-stage NSCLC. The digital curriculum will incorporate real-time activities; collaborative, small group discussions and tasks; self-study modules; and a social learning platform. ACCC is currently recruiting Group Leaders (3-4 hours time over 8 weeks; honorarium provided) and Group Participants (2.5 hours time over 8 weeks).
We take a look at how the COVID-19 pandemic has impacted lung screenings across the country and how oncology teams are adapting their outreach and education to reach as many people as possible.
We mark the beginning of Lung Cancer Awareness Month by looking at the present landscape for the diagnosis and treatment of one of the most common cancers in the world.
Learn how two cancer programs used a unique quality improvement model to improve care for lung cancer patients who are uninsured or on Medicaid.
Hear More Podcasts